China outlicensing tops US$52 billion in first two months on rise in global deals

--------------------------------------------------------------------
Source: South China Morning Post
Published: 2026-03-04 20:30 UTC+10:00
Section: Brussels
Factuality Score: 100
Opinion Category: Neutral
Topics: Asia, Europe, China, World News, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
The latest deals are Sino Biopharmaceutical’s partnership with France’s Sanofi and Antengene’s agreement with Belgium’s UCB
--------------------------------------------------------------------
>>> Read full article at South China Morning Post <<<
<-- Back to Home
< >
[Close]